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INTRODUCTION
The tongue is a vital structure essential for initiating the first phase of 
swallowing, moving food in the oral cavity to permit adequate mastication, 
to enjoy the taste of delicious food and of course for articulation. In toto it 
makes  the  life  lively  and  lovely.  Therefore  it  is  no  wonder  that  any 
abnormality of the tongue will cause the patient significant dysfunction.
In India, cancer of the tongue occurs in approximately 30,000 people 
in a year nearly 7500 persons die of carcinoma tongue.
Early detection is the key to an effective cure of carcinoma tongue 
with minimal disability.
Unfortunately in our part of the world the people are more prone to 
develop oral cancers because of tobacco habituation in various forms, and 
also report for treatment at advanced stage because of various reasons. 
AIM OF THE STUDY
1. To study the various anatomical site wise distribution of carcionoma 
tongue in southern Tamil Nadu.
2. To study about various predisposing factors, age, sex distribution of 
carcinoma of the tongue.
3. To compare the merits and demerits of various modalities of treatment 
like surgery, radiotherapy and chemotherapy in combination or alone.
4. To evaluate the guide lines for the future management of carcionoma 
of the tongue and to give the maximum benefit to the suffering 
patients.  
SURGICAL ANATOMY OF TONGUE
The  tongue  is  a  highly  muscular  organ  of  deglutition,  taste  and 
speech. Partly oral and partly pharyngeal in position and is attached by its 
muscles to the hyoid bone,  mandible,  styloid process,  soft  palate and the 
pharyngeal wall.
It has a root, apex, a curved dorsum and an inferior surface. Mucosa is 
normally pink, moist, and attached closely to the underlying muscles. The 
root of the tongue is attached to the hyoid bone and mandible. Dorsum is 
divided by V shaped sulcus terminalis into an anterior, oral or presulcal part 
which is facing upwards and  Posterior, pharyngeal or postsulcal part facing 
posteriorly which forms posterior 1/3 of the tongue.
The  two  limits  of  sulcus  terminalis  run  anterolaterally  to  the 
palatoglossal arches from a median depression called foramen ceacum which 
is the site of upper end of the embryonic thyroid diverticulum.
TONGUE – ORAL PART:
 
Located  in  the  floor  of  the  oral  cavity,  has  an  apex  touching  the 
incisior teeth, a margin in contact with the gums and teeth. Superior surface 
is related to hard and soft palates. Dorsal mucosa has a longitudinal median 
and is papillated.
The inferior mucosa is smooth, purplish and reflected on to the oral 
floor and gums, which is being connected to the former anteriorly by the 
median muscular fold – frenulum linguae. Lateral  to this on either side deep 
lingual  veins  are  visible.  Lateral  to  the  veins  is  a  fringed mucosal  ridge 
called as plica fimbriata.
PHARYNGEAL PART:
Forming  the  base  of  the  tongue  lies  posterior  to  the  palatoglossal 
arches within oropharynx. Its mucosa is reflected laterally on to the palatine 
tonsils and pharyngeal wall and posteriorly on to the epiglottic folds. Devoid 
of papillae it has low elevations due to lymphatic nodules embedded in the 
submucosa,  which  are  collectively  called  as  lingual  tonsil.  The  ducts  of 
small seromucous glands open on the apices of these elevations.
DEVELOPMENT OF TONGUE:
Anterior 2/3 of the tongue develops from the lingual swellings of the 
mandibular arch and form the tuberculum impar. Posterior 1/3 of the tongue 
develops from the hypobranchial eminence.
LINGUAL PAPILLAE:
These are projections of mucosa from the dorsum of the tongue which 
are limited to anterior 2/3 of the tongue. There are 4 types. These projections 
are modifications of mucous membrane which increase the area of contact 
between the tongue and the contents of the mouth. The four types are
1.filiform papillae
2. fungiform papillae
3. vallate papillae
4. others.
LINGUAL MUSCULATURE:
Tongue is divided by a median fibrous septum attached to the hyoid 
bone. In each half are both the extrinsic and intrinsic muscles.
Extrinsic muscles:
Genioglossus: triangular in sagittal section, linear and parallel to the 
midline,  arises  from  superior  genial  tubercle  behind  the  mandibular 
symphysis.  From this point  its  fans out  backwards and upwards.  Inferior 
fibres  of  genioglossus  are  attached  by  a  thin  aponeurosis  to  the  upper 
anterior surface of the hyoid body near the midline.  Muscles of opposite 
sides are separated posteriorly by the lingual septum. Genioglossus brings 
about forward traction of the tongue and acting bilaterally, the two muscles 
depress the central part of the tongue, acting unilaterally the tongue diverges 
to the opposite side. The nerve supply is hypoglossal nerve.
Hyoglossus: Thin, quadrilateral muscle attached to the whole length 
of the greater cornu and the front of the body of the hyoid bone. Passing 
almost  between styloglossus laterally and the inferior longitudinal muscle 
medially. Hyoglossus depresses the tongue and is supplied by hypoglossal 
nerve.
Chondroglossus:  This is described as a part of hyoglossus. 2cm in length 
arises from the medial side and base of the lesser cornu and the adjoining 
part of the hyoid body and ascending to merge with theinrinsic musculature 
between  the  hyoglossus  and  genioglossus.  The  action  is  to  assist  the 
hyoglossus to depress the tongue.
Styloglossus:  Shortest  and smallest  of the three styloid muscles.  It 
arises from the anterolateral aspect of the styloid process near its apex amd 
from the down and forwards,  it  divides at the side of  the tongue in to a 
longitudinal part which enters the tongue dorsolaterally and an oblique part 
overlapping the hyoglossus and decussating with it. The action is to draw the 
tongue up and backwards and is supplied by hyoglossus nerve.
Palatoglossus: Arises from the palatine aponeurosis of the soft palate 
inserted to the side of the tongue at the junction of the anterior 2/3rd and 
posterior 1/3rd, elevates the tongue and opposes it with the soft palate. The 
nerve supply is cranial accessory.
INTRINSIC MUSCLES:
Superior longitudinal muscle: extends forwards from the submucous 
fibrous tissue near the epiglottis and from the median lingual septum into the 
lingual margins. Some fibres being inserted into the mucous membrane.
Inferior longitudinal  muscle:  Close  to  the inferior  lingual  surface 
between genioglossus and hyoglossus. Extends from the lingual root to the 
apex. Some of its posterior fibres being connected to the body of the bone 
and anteriorly blends with styloglossus.
Transverse muscles: Passes laterally from the median fibrous septum 
to  the  submucous  fibrous  tissue  at  the  lingual  margin  blending  with 
palatopharyngeus.
Vertical Muscles: Extend from the dorsal to the ventral aspects of the 
tongue  in  the  borders  of  its  anterior  part.  All  the  intrinsic  muscles  are 
supplied by hypoglossal nerve.
Intrinsic  muscles  of  the  tongue alter  the shape  of  the tongue.  The 
superior and inferior longitudinal muscles shorten the tongue. The former 
also turn the apex and sides upwards to make the dorsum concave, later pulls 
the apex down to make the dorsum convex.
Transverse muscle narrows and elongates the tongue. Vertical muscle 
makes  it  flatter  and  wider.  Acting  alone  or  in  pairs  and  in  endless 
combination  they  give  the  tongue  precise  and  highly  variable  mobility. 
Important not only in alimentary function but also in speech.
LINGUAL GLANDS:
Three types: Mucous, serous and mixed types. Mucous glands are like 
the labial  and buccal  glands in structure.  They are  numerous  in  the post 
sulcal region, and also present at the apex and margins.
TASTE BUDS: 
Taste buds are little barrel shaped pale staining structures arranged at 
right angles to the surface of the mucous membrane of the mouth and the 
throat. They present plenty on the dorsum of the tongue particularly along 
the sides  of  the groove that  surround the vallate  papillae  and epithelium 
between  the  paplillae.  A  taste  bud  is  spindle  shaped  and  has  a  layered 
appearance like an onion under the microscope.
 Two kinds of cells called sustencular cells and neuroepithelial taste 
cells are present. Sustencular cells are narrower at their ends and they pursue 
a curved course from one end of the bud to the other. The end of the bud 
reaches the surface and there are cells which are arranged so as to surround a 
little pit that opens on the surface through fine inner taste pores.
The neuroepithelial cells which are long narrow cells are intermingled 
with sustencular cells in the more central part of the bud. The free ends of 
these cells extend into the pits at the end of taste bud. They give rise to short 
hairs that extend into the pit.
Any substance to be tasted gets dissolved in saliva and passes by means of a 
pore  into  the  pit  of  the  taste  bud  where  it  stimulates  the  hairs  of  the 
neuroepithelial cells setting up a nerve impulse. There are basic tastes like 
sweet, sour, salty, bitter and perhaps alkaline and metallic.
NERVE SUPPLY OF THE TONGUE:
SENSORY NERVES: 
Lingual branch of mandibular  nerve is for  general sensation of the 
anterior 2/3rd of tongue. Chorda tympani branch of the facial nerve running 
in  the  sheath  of  lingual  nerve  for  gustation  in  the  anterior  2/3rd region 
exclusive of vallate papillae.
Lingual  branch  of  the  glossopharyngeal  nerve  distributed  to  the 
posterior 1/3rd mucosa, lateral aspect and to the vallate papillae. It mediates 
general  and  gustatory  sensation.  Superior  laryngeal  nerve  sends  fine 
branches to the root immediately infront of the epiglottis.
MOTOR INNERVATION:
Motor supply to all lingual muscles except palatoglossus is through 
hypoglossal nerve. Palatoglossus is supplied by pharyngeal plexus.
Parasympathetic supply:
Parasympathetic supply of the various glands of the tongue is 
from chorda tymphani which is a branch of facial nerve. It get synapsed in 
the submandibular ganglion and then distributed to the tongue mucosa via 
the lingual branches.
Sympathetic supply:
Sympathetic  supply  to  lingual  glands  and vessels  enters  in  tongue 
through  the  plexus  around  its  arteries  arising  from  carotid  plexus.  In 
posterior 1/3rd of the tongue isolated nerve cells have been observed perhaps 
post  ganglionic  parasympathetic  neurons  probably  innervating  glandular 
tissue and vascular smooth muscles.
ARTERIAL SUPPLY:
Main arterial supply is through lingual branch of the external carotid 
artery.  Tonsillar,  ascending palatine branches of the facial  and ascending 
pharyngeal arteries also supply the lingual root.
  In the vallecula, epiglottic branches of the superior laryngeal artery 
get  anastamosis  with  the  inferior  dorsal  branches  of  the  lingual  artery. 
Lingual muscles are supplied by this rich anastamotic network and there is a 
very dense submucosal plexus.
VENOUS SUPPLY:
Dorsal lingual veins drain the dorsum and sides of the tongue and join 
the lingual veins which accompany the lingual artery between hyoglossus 
and genioglossus. Near the greater cornu of the hyoid bone, they join the 
internal jugular vein. Deep lingual veins drain the tip of the tongue. Near the 
anterior border of hyoglossus it joins a sublingual vein. 
LYMPHATIC DRAINAGE:
Lymphatic plexus in the lingual mucosa is continuous with an 
intramuscular plexus.  The anterior lingual region drains into the marginal 
and central vessels and behind the vallate papillae into the dorsal lymph 
vessels.  Vessels are divided into marginal, central and dorsal vessels.
Marginal Vessels:
They come from lingual apex and frenular region and descend under 
the mucosa to widely distributed nodes.  Some vessels pierce the mylohyoid 
in contact with mandibular periosteum to enter the submental nodes and also 
pass anterior to   the hyoid bone to jugulo-omohyoid node.  Vessels arising 
in  the  plexus  on  one  side  may  cross  under  the  frenulum to  end  in  the 
contralateral nodes.  Efferent vessels of submental nodes which are median, 
pass to both sides.  Some vessels pierce the mylohyoid to enter anterior or 
middle submandibular  nodes.   Some pass inferior to the sublingual gland 
and accompany the companion vein of the hypoglossal nerve and in jugulo-
digastric  nodes.   One  often  descent  further  superficial  or  deep  to  the 
intermediate  tendon of the diagastric to reach the jugulo-omohyoid node. 
Some vessels from the lateral margin cross the sublingual gland pierce the 
mylohyoid  and  end  in  the  submandibular  nodes.   Others  end  in  jugulo-
digastric or jugulo-omohyoid nodes.  Vessels from the posterior part of the 
lingual margin traverse the pharyngeal wall  to the jugulo-digastric lymph 
nodes.
Central Vessels:
The regions of the lingual surface draining into the marginal or central 
vessels are not distinct.  Central vessels descend between the genioglossi, 
some turning laterally through the muscles, but most pass between them and 
diverge to the right or left following the lingual veins to the deep cervical 
nodes especially the jugulo-digastric and jugulo-omohyoid.   Some pierce 
the mylohyoid to enter the submandibular nodes.
Dorsal Vessels:  
Draining  the  region  of  the  vallate  papillae  and  behind  them  run 
postero-inferiorly.  Some near the median plane to both sides.  They run 
laterally to join the marginal vessels, all pierce the pharyngeal wall, passing 
around the external carotid arteries to reach the jugulo-digastric and jugulo-
omohyoid nodes.  One may descend posterior to the hyoid  bone, perforating 
the thyrohyoid membrane to end in the jugulo-omohyoid node.
Significant feature of the lymphatic drainage of the tongue, which is 
through  the  floor  of  the  mouth,  is  that  from one  side  especially  of  the 
posterior part may reach  nodes of both sides of the neck.  This contralateral 
flow usually only occurs when the ipsilateral channels have been obstructed.
RISK FACTORS FOR THE DEVELOPMENT OF CARCINOMA OF 
THE TONGUE
The risk factors are 
1. Tobacco
2. Alcohol
3. Chronic irritation due to sharp teeth etc.,
4. Vitamin deficiencies
TOBACCO:
Tobacco appears to be a risk factor for most cancers originating in the 
tongue.  Relative  risk  of  cancer  of  the  tongue  increases  with  increasing 
amount  and  duration  of  tobacco  use.  Wynder  and  stellman  estimated  a 
relative risk for 4.8 for men who smoked 1-5 cigarettes per day and 8.1 for 
those who smoked 10 or more cigarettes per day, when compared with non 
smokers. Tobacco appears to act as an initiator as well as promoter and the 
relative risk decreased after cessation of smoking.
ALCOHOL:
Alcohol has been implicated as a risk factor for oral, pharyngeal and 
laryngeal cancers. Overall risk of cancer of the oral cavity and pharynx was 
found to be positively associated with the amount of any type of alcohol 
consumed (beer, wine or hard liquor). William and Horn reported the highest 
relative risks for oral cavity and larynx cancer among male beer drinkers and 
for pharyngeal cancer among wine drinkers. Liber et al reviewed possible 
mechanisms  by  which  alcohol  abuse  or  related  disease  may  initiate  the 
development of cancer.
1. Local effect due to direct contact: direct contact with susceptible 
tissues may increase the risk of cancer through carcinogens in the 
consumers of alcohol.
2. Presence  of  carcinogens:  Some  of  the  containments  in  alcohol 
beverages are Polycyclic hydrocarbons, fuel oil and nitrosoamines 
which are carcinogens.
3. Cellular  injury  produced  by  ethanol  and  its  metabolite 
acetaldehyde  affect  target  tissues.  After  chronic  ethanol 
consumption hepatic mitochondria become more susceptible to the 
toxic  effects  of  acetaldehyde.  Although mutagenicity  of  ethanol 
has  not  been  demonstrated,  acetaldehyde  has  been  found  to  be 
mutagenic for human lymphocytes.
4. Nutritional  deficiencies:  Alcoholics  have  nutritional  deficiencies 
which has been associated with development of malignancies.
CHRONIC IRRITATION:
Trauma and local irritation are considered extremely important in the 
etiology of carcinoma tongue. Malocclusion producing chronic cheek bite, 
ill fitting dentures, sharp teeth which constantly irritate the mucosa.
Hot spicy foods are also to be considered as risk factors.
Poor oral and dental hygiene are also one of the predisposing factors.
VITAMIN DEFICIENCIES:
It  is  well  recognized  that  a  deficiency  of  vitamin  A  will  induce 
metaplasia and keratinization of certain epithelial structures, particularly of 
the glands of the respiratory mucosa. Vitamin B complex deficiency has also 
been  suggested  as  a  predisposing  factor  which  must  be  related  to  the 
alteration in the oxidation patterns of the epithelium.
PREMALIGNANT LESIONS
A premalignant  lesion is  a morphologically  altered tissue in which 
malignancy is more likely to occur.
The premalignant lesions are 
1. Leukoplakia
2. Erythroplakia
3. Submucous fibrosis
4. Carcinoma in situ
LEUKOPLAKIA:
It is a white plaque on the oral mucous membrane produced by several 
conditions  including  epidermal  proliferations  like  tobacco,  chronic  cheek 
bite,  lichen  planus,  palatitis  nicotina  and  candidiasis.  By  definition 
Leukoplakia is a white plaque on the oral mucous membrane that cannot be 
removed by scraping and cannot be classified clinically and  microscopically 
as another disease entity.
ERYTHROPLAKIA:
Red, velvety, possibly eroded area with in the oral cavity that usually 
remains  level  with  or  may  be  slightly  depressed  in  relation  to  the 
surrounding  mucosa.  The  epithelial  changes  in  such  lesions  tend  to  be 
markedly atypical, incurring a much higher risk of malignant transformation 
(18-20%) than that of leukoplakia (5-9%)
SPECKLED LEUKOERYTHROPLAKIA:
Occasionally  intermediate  forms  are  encountered  that  have  the 
characteristics  of  both  leukoplakia  and  erythroplakia.  They  appear  as 
solitary/multiple white patches or plaques with indistinct/sharply demarcated 
borders.  They may  be  slightly  thickened,  smooth,  wrinkled,  indurated  or 
may appear as raised. Sometimes they are corrugated or verrucous plaques. 
Histologically  they  present  as  an  epithelial  spectrum  ranging  from 
hyperkeratosis overlying a thickened, acanthotic but orderly placed mucosal 
epithelial  lesions  with  markedly  dysplastic  changes.  Sometimes  they  are 
merged with carcinoma in situ.
SUBMUCOUS FIBROSIS:
It is defined as an insidious chronic disease affecting any part of the 
oral cavity and sometimes the pharynx. Although preceded occasionally by 
vesicle formation, it is always associated with juxta epithelial inflammatory 
reaction followed by fibroelastic change of lamina propria with epithelial 
atrophy  leading  to  stiffness  of  the  oral  mucosa  and  causing  trismus  and 
inability to eat.
It  may  be  related  to  a  particular  dietary  component  like  chillie. 
Histology shows atrophy of oral epithelium with complete loss of rete pegs. 
Underlying  connective  tissue  shows  severe  hyalinization  with 
homogenization of collagen bundles.
SQUAMOUS CELL CARCINOMA:
More  than   95%  of  the  Malignancy  of  tongue  are  squamous  cell 
carcinoma 2% of all cancer deaths in male, 1% of all cancer death in female 
are  due to  squamous cell  carcinoma tongue.   In  early  stages  malignancy 
appear either as raised, firm, plaques or as irregular, roughened or verrucous 
area of mucosal thickening possibly mistaken for leukoplakia.  Either pattern 
may  be  superimposed  on  a  background  of  apparent  leukoplakia  or 
erythroplakia.  As these lesions enlarge they create, protruding masses and 
undergo  central  necrosis  forming  an  irregular,  shaggy  ulcer  rimmed  by 
elevated, firm, rolled border.  Squamous cell carcinomas of the oral cavity 
take  months  to  years  to  progress  from  carcinoma  in  situ  often  being 
preceded by leukoplakia to invasive cancer and so every death they cause 
must be viewed as a preventable tragedy.
THE ROLE OF SURGICAL PATHOLOGY IN 
DIAGNOSIS AND MANAGEMENT
Surgical biopsy:
The simplest and most commonly utilized method is ‘Punch biopsy’. 
Histological diagnosis is straight forward mostly.  Exophytic lesions which 
are highly differentiated at the surface, i.e., verrucous carcinoma may not 
yield tissue, truly representative of the growth.  Ulcerative lesions which are 
post  irradiation  recurrence  may  be  difficult  to  punch.   For  these  cases 
‘wedge biopsy’ or incision biopsy has to be taken.
Fine Needle Aspiration Cytology:
It  is  an  excellent  technique  for  confirming  metastatic  disease  in 
enlarged lymph nodes.  Sometimes micrometastasis may be missed due to 
sampling error. Accuracy is about 40%. 
Frozen section Biopsy:
Mostly used intraoperatively to determine the status of cervical lymph 
nodes and excision margin.  Frozen section are used for primary diagnosis of 
squamous cell carcionoma of the tongue.
Tumour thickness and depth of invasion:
The depth of invasion is the portion of tumour below the plane  of 
normal  surrounding  mucosa.   Tumour  thickness  correlates  well  with 
survival.
PATHOLOGICAL  CLASSIFICATION  OF  CARCINOMA 
TONGUE:
1. Squamous cell carcinoma.
2. Tumour arising from minor salivary glands.
- Adenoid cystic carcinoma
- Mucoepidermoid carcinoma
- Lymphoma.
3. Soft tissue sarcoma
4. Mucosal melanoma
5. Plasmacytoma
AJCC – STAGING OF  ORAL CANCERS
Tx - Primary tumour cannot be assessed
To - No evidence of primary tumour.
Tis - Carcinoma in situ.
T1 - Tumour 2cm or less in greatest dimension.
T2 - Tumour more than 2 cm but not more than 4cm in greatest 
dimension.
T3 - Tumour more than 4cm in greatest dimension.
T4 - Tumour invades adjacent structures.
T4a -         Tumour involving cortical bone, deep (extinsic) muscle of 
tongue, maxillary sinus and floor of the mouth.
T4b - Tumour invades masticator space, pterygoid plates of skull 
base.
STAGING OF CERVICAL LYMPH NODES
Nx - Regional nodes cannot be assessed.
No - No Regional lymph node metastasis.
N1 - Metastasis in single ipsilateral lymph node 3 cm or less in
greatest dimensions.
N2a - Metastasis in single ipsilateral lymph node more than 3 cm but 
not more than 6cm in greatest dimension.
N2b - Metastasis in multilple ispilateral lymph node, none is more
than 6cm in greatest dimension.
N2c - Metastasis in bilateral or contralateral lymph nodes, none more 
than 6cm in greatest dimension.
N3 - Metastasis in a lymph node more than 6cm in greatest 
dimension.
DISTANT METASTASIS
Mx - Presence of distant metastasis can not be assessed.
Mo - No distant metastasis
M1 - Distant metastasis
STAGING
STAGE  I - T1N0M0
STAGE II - T2N0M0
STAGE III - T3N0M0T1,2,3N1,M0
STAGE IV - T4N0M0, T1,2,3,4 N2,3M0  any T, and N, M1
LEVELS OF NECK NODES
Level-Ia: Nodes in submental triangle.
          Ib: Nodes in Submandibular triangle
Level-II: Jugular nodes extending from the subdigastric area down to the 
carotoid bifurcation and the nodes surrounding the spinal  accessory nerve 
from jugular  foramen  to  the  posterior  border  of  sternomastoid.   Includes 
nodes in the upper posterior cervical triangle above the entrance of the spinal 
accessory nerve in to this triangle.
Level III: Nodes along the middle 1/3 of the internal jugular vein-between 
the cartoid and its bifurcation to the posterior border of the sternomastoid 
and the omo hyoid muscle or cricothyroid membrance.
Level  IV: Nodes along the lower 1/3 of the internal jugular vein between 
the omohyoid muscle above, the clavicle below, behind the carotid vessels 
and anterior to the omohyoid muscle.
Level V: Nodes  in  the  posterior  triangle  –  Borders  are  formed  by 
posterior edge of the sternocleido mastoid muscle, the level of the entrance 
of the spinal accessory nerve, the trapezius muscle, the posterior belly of the 
omohyoid muscle.
Level VI: Pretracheal, paratracheal and  anterior cervical node group.
APPROACH TO THE CARCINOMA TONGUE PATIENTS
The comprehensive care of carcinoma of the tongue patients begin 
with pretreatment consideration that include the assessment of the general 
medical  condition,   nutritional  status,   dental  and  oral  hygiene,  and 
appropriate  choice  of  medical  therapies  that  designed  to  minimise  the 
treatment  related complication.   Confirmation  of the diagnosis   by tissue 
biopsy, the nodal secondaries mostly confirmed  by FNAC.  To rule out lung 
and liver metastasis we have to do X-ray chest and ultrasonogram Abdomen 
studies.
Common  microbials  isolated  from  infected  wounds  include  both 
aerobes  and  anaerobes  with  Bacteroids  fragilis,  E.coli,  β Hemolytic 
streptococci, staphylococcus, pseudomonas.  Perioperative antibiotics should 
continue  for  72  hours  post  operatively  depending  on  the  likely  hood  of 
infection.  Antibiotics regimen should allow for broad spectrum coverage. 
Antibiotics  should  include  sulbactum  and  ampicillin  or  Metronidazole 
combined with cephalosporins. 
LITERATURE REVIEW OF VARIOUS MODALITIES OF 
TREATMENT
General Principles of surgery in carcinoma of the tongue:
In  the delivery of effective  surgical management,  the single most 
significant principle is the adequate preoperative assessment of the disease 
extent.   Adequate surgical clearance has to be given to the diseased site. 
For surgery, electrocautery dissection, Laser ablation and Harmonic scalped 
can  be utilized.  Recent development in the management of cervical lymph 
node  disease  involve  more  conservative  surgical  procedure.   In  those 
patients who are not likely to receive careful post operative follow up,  it is 
recommended that elective radical  neck dissection can be performed.
General principles of Radiation therapy:
For  early  state  disease  both  radiation  and  surgery  are  frequently 
curative and can produce similar rates of cure.  Selection of treatment can be 
individualized to each patient and must  consider issues like cosmetic and 
functional  outcome,  quality  of  life,  speed  with  which  treatment  can  be 
completed, patient, reliability, risk of subsequent cancers etc., If surgery is 
planned, there is no indication for  pre-operative radiotherapy.  Definitive 
surgery should be performed and post operative radiotherapy can be used. 
In  planning  treatment  for  advanced  lesions  it  is  essential  to  separately 
consider the primary site and the metastatic neck.  Adequate dose of well 
delivered post operative radiotherapy can sterilize cancer positive surgical 
margins.   Side  effects  of  radiotherapy  are  classified  into  acute  and  late 
complications.  Acute effects generally related to inflammatory reactions in 
the  tissues  within  the  radiation  field  like  epidermitis,  mucositis,  loss  of 
taste.  Irradiation of salivary glands cause dryness of mouth. Irradiation of 
lacrimal glands can cause dryness  of the eyes.
Any dental works should be done prior to the initiation of radiation. 
Patient should be placed on dental prophylaxis with fluoride application.  It 
has also been clearly shown that dental extraction in an irradiated mandible 
can lead on to osteonecrosis.
Combined external beam irradiation plus brachytherapy is commonly 
employed for cancers of the  tongue.  This allows very high doses to the 
tumour  with  implant  which  also  serves  to  minimise  radiation  to  the 
surrounding normal tissue.  This will serve to increase the local  control as 
well  as  to  improve  the  functional  and  quality  of  life  outcome. 
Brachytherapy alone can be used for early lesion of the tongue and external 
RT to be held in reserve for potential future use.
External  radiotherapy is  usually  delivered once a  day.   5  days per 
week, continuous course until the desired dose is achieved.  In general 50-60 
cGY in 5-6 weeks.  Because the anatomic separation in the head and neck 
region is thinner than other parts of the body, a low energy linear accelerator 
is preferred.
General Principles of Chemotherapy:
Neo Adjuvant Chemotherapy: Given  before  ablative  surgery  or 
radiotherapy,  the  main  advantage  is  preservation  of  the  organ  function, 
Neoadjuvant  chemotherapy  eliminates  the  pharmocologic  sanctuary 
problems  that  is  poor  vascularity  leading  to  the  poor  concentration  of 
chemotherapy after surgery or radiotherapy.  Initial chemotherapy result is 
increased compliance, responsiveness and tolerance of higher dosage.  Down 
staging of the primary and regional node disease has successfully allowed 
for organ preservation and reduction in distant micrometastasis.  Cisplatin 
and 5FU combination remains the most active regimen.
Post  Operative adjuvant  chemotherapy:
Chemotherapy  administered  after  the  patient  has  been  rendered 
disease free with surgery or radiotherapy.  The rationale behind that, are, for 
resectable  disease  definitive  surgery  is  not  delayed.   When neo adjuvant 
chemotherapy is successful, tumour  margins are blurred and the extent of 
the  required  surgery  may  be  uncertain,  in  trials  of  neo  adjuvant 
chemotherapy  up to  20% of  patients  refused  surgery  once  response  was 
achieved and their symptoms abated.
There was a significant increase in time to develop distant metastasis 
for  patients  receiving  adjuvant  chemotherapy.   The  overall  comparison 
shows  there  is  no  significant  difference  in  overall  survival,  disease  free 
survival or time to loco regional failure with adjuvant chemotherapy.
Concurrent chemotherapy:
The  purpose  of  simultaneous  chemo  radiation  is  to  increase  loco-
regional control and to prevent distant metastasis.  The possible synergistic 
effect has been explained by drugs interface with cell repair after sublethal 
or  potentially  lethal  damage or  with tumour  cell  synchronization.   Trials 
show  positive  results  for  the  strategy  of  alternating  chemotherapy  and 
radiotherapy  compared  with  radiotherapy  or  chemotherapy  alone  or  neo 
adjuvant  followed  by    radiotherapy.   In  additional  mucosal  toxicity 
associated  with  this  protocol  appears  acceptable  and  similar  to  that  of 
radiotherapy alone.
Drugs used for chemotherapy:
Methotrexate:  The  standard palliative drug for  recurrent  squamous cell 
carcinoma.  Dose is 40mg/m2/week, slowly increased upt 60mg / m2 / week 
– until toxicity or objective response is achieved.
Bleomycin: Response  vary  from  6-45%  average  is  21%.   Continuous 
infusion of bleomycin produces less pulmonary toxicity than bolus injection.
Cisplatin: Most  important  drug  for  squamous  cell  carcinoma  of  the 
tongue.  80-100mg/m2 in every 3-4 weeks.  Response rate is 28%.
5 Flourouracil: Usually  given  as  IV  bolus  for  5  days.   %FU 
administrated  as  infusion  instead  of  bolus  was  found  to  have  increased 
activity, synergistic interaction with cisplatin and enhanced cytotoxicity with 
modulators like leucovarin.
Taxanes: Paclitaxel  and docetaxel  binds to  the  β sub unit  of   tubulin, 
induce the formation of stable microtuble bundles and inhibit microtubule 
depolymerisation.  Response rate is 30-40%.  Paclitaxel 250 mg / m2 and 24 
hours infusion in every  3 weeks.  Docetaxel 100m /m2 IV bolus in every 3 
weeks.
Biologic Therapy for Recurrent Squamous Cell Carcinoma
Patients have moderate to severe depression of cellular and humoral 
immunity which may be reduced even further by surgery or radiotherapy. 
Cell  lines express high affinity to IL-2 receptors and growth inhibited by 
IL-2  in  vivo  and  vitro.   It  has  been  shown  that  tumour  infiltrating 
lymphocytes  can  be  increased  to  30,000  folds  by  IL-2.   Systemic  IL-2 
combined  with  Interferon  has  anti  tumour  activity  but  with  substantial 
toxicity.  Research currently focuses on the best way to combine cytokines, 
retinoids, cytotoxic agents, and radiation therapy.
Principles of Chemoprevention 
Chemoprevention is administration of natural or synthetic agents  to 
reverse  or   suppress  carcinogenesis  before  the  development  of  invasive 
cancer.    β Carotene or retinol have been extensively studied.  Retinoids 
modulate  the  growth  and  differentiation  of  normal,  premalignant  and 
malignant epithelial cells in culture and can suppress cancinogenesis in vivo 
in  various  human  epithelial  tissues.   Agents  used  are  selenium  and  α 
tocopherol,  β carotene, cis retinoids.  They are used to treat premalignant 
lesions like leukoplakia etc but used only in trials.
TREATMENT OF CARCINOMA OF THE TONGUE
Early Disease:
Generally considered that disease control rates for early disease when 
using either surgery or radiation are equivalent depending on treatment bias. 
Surgical excision usually entails a hemiglossectomy.  Special attention to 
surgical margins should be exercised.  Since disease may spread along the 
muscle bundles, most T1 lesions can be managed by brachytherapy alone 
that  is  Iridium  192  implant.   Iridium  192  is  inserted  via  after  loading 
catheters.  Catheters  are  placed  in  the  operating  room  under  general 
anesthesia.  Iridium 192 is loaded for 1-2 days.  Localization films are taken 
and computerised dosimetry is performed.  Usually dose is 40-60 cGY per 
hour range and usual total dose is 6000-7000 cGY.
The patient wears tongue prosthesis during dwell time of the implant 
to protect the hard and soft palate as much as possible.  Because the lesion 
increases in size when using radiation as primary therapy it is preferred to 
combine  external  beam  irradiation  with  implant.   First,  external  beam 
irradiation can be used as elective neck irradiation simultaneous with tongue. 
The implant then serves as the boost to the tongue.  Secondly, the external 
beam radiotherapy allows a wider margin of tongue to be treated than does 
the implant.  External RT 5000cGY (200 cGY / day, 5 days a week for 5 
weeks).  Radiation is certainly suitable for T1 lesions.
Carcinoma of the tip of the tongue:
Excise this in a ‘V’ shaped fashion, giving adequate margin so that a 
new tongue tip can be made.
Carcinoma of the dorsum of the tongue:
Tumour less that 2cm in diameter, excise it in an ellipse and close the 
tongue  primarily.   It  can  also  be  treated  with  radiotherapy  primarily. 
Surgical treatment for larger tumours would require an extensive operation 
and  so  radiotherapy  is  preferred.   Large  tumours  cannot  be  treated  by 
interstitial  radiotherapy  alone,  external  beam  radiotherapy  has  to  be 
combined.
Carcinoma of the lateral border of the tongue:
If  no  glands  are  palpable  then  the  choice  lie  between  interstitial 
irradiation and partial glossectomy.  If tumour is greater than 3 cm in size 
then  either  external  beam  irradiation  is  used  or  hemiglossectomy  is 
performed.
Base of the tongue:
Treatment  varies  according  to  different  institutions.   Some  centers 
advise  radiotherapy as  a primary modality  and surgery for  failures.   But 
surgery  following  radiotherapy  improves  the  survival  only  by  10%.   So 
initial surgery followed by post operative radiotherapy is recommended to 
improve  the  dismal  prognosis.   Irradiation  of  Carcinoma  of  the  base  of 
tongue is delivered by parallel opposed external beam portals to the primary 
site, which also includes the bilateral regional lymph nodes.
Surgical Techniques of Tongue Cancer:
Local Excision of Tongue Cancers:
Many tongue cancers of 1.5cm or less can be managed successfully by 
local sharp or LASER excision.  Excise it with 1cm margin.  If the excision 
is  done by a  LASER it  is  said that  grafting of the defect  is  not  needed, 
otherwise the defect must be repaired with graft.
Hemiglossectomy:
Voice  must  be  considered  before  going  for  this  operation.   If  the 
patient depends on the voice for a livelihood then attempts must be made to 
leave a good tip of the tongue.  Question of standing teeth will also have to 
be considered.  If the patient is to have pre or post operative radiotherapy 
then all those teeth should be removed before radiation.  If primary surgery 
is being used then only bad teeth are to be removed.
Advanced Carcinoma of the tongue:
Requires  mandibulectomy  or  lingual  releasing  procedures  to  gain 
access to displaced part.  The later procedure entails removal of the neck 
contents prior to primary cancer resection.  The tongue is delivered into the 
neck  by  releasing  musculature  attachments  posteriorly  and  mucosal 
attachments  within  the  oral  cavity.   Large  lesions  with  mandibular 
involvement will require composite resection.  The term composite resection 
means  removal  of  the  tissue  involving  multiple  anatomically  defined 
structures, one of which includes mandible.  Typically it refers to resection 
of portion of the tongue, floor of the mouth, segment of the mandible.
Treatment Policy for Carcinoma of the tongue:
1. Surgery  has  no  part  in  the  treatment  of  Sarcoma  or  Lymphoma. 
Treatment is based on radiotherapy.
2. T1 and early  T2 tumours  treated by either  surgery or  radiotherapy 
alone.  Larger T2 and smaller T3 lesions are best treated by surgery.
3. Massive tumours do very badly with any treatment and best may be 
treated symptomatically.
4. Radiotherapy  of  the  oral  cavity  requires  that  the  mandible  will  be 
irradiated greater or lesser extend.  Osteonecrosis of the mandible is a risk 
even  if  no  further  surgery  is  performed.   But  it  is  an  almost  certain 
complication if anything other than wide resection of the mandible is done in 
any salvage surgery.   If  mandible  has been irradiated,  later  excision and 
bone grafting will be impossible.
5. Radiotherapy  does  not  cause  dental  caries.   It  does  however 
predispose  to  periodental  disease,  which  in  turn  causes  marginal  caries. 
Dental extraction before radiotherapy is not mandatory, if future dental care 
will be regular and thorough.  If however the teeth are initially poor and the 
patient is not dentally conscious, then all the teeth should be extracted and 
sockets stitched 10 days before radiotherapy.
6. In case of small (T1 or T2) tumour with  no palpable neck nodes – the 
nodes are irradiated in enbloc with primary.  Elective irradiation of the lower 
neck is not necessary.  Patient irradiated for large primary with no palpable 
nodes should receive prophylactic neck irradiation.If, No neck nodes and the 
primary lesion is treated surgically then the elective Radical neck dissection 
is performed.
Post treatment Rehabilitation:
No doubt as we see the limitations of current therapeutic strategies to 
improve on mortality rates for advanced disease, quality of life issues will 
become increasingly important.  Rehabilitation approach begins before the 
initiation of the treatment – post treatment should begin as early as possible, 
depending upon the healing and integrity of surgical wounds.  Appropriate 
rehabilitation of tongue begins with choice of reconstruction.   Resections 
contribute  sensory  loss  which  impairs  initial  phase  of  degultition.   The 
optional  reconstruction  in  most  circumstances  involves  primary  closure 
thereby minimizing large insensate contact surfaces.
Reconstruction:
The principle of reconstruction after glossectomy varies according to 
the extent of tongue resection.  If the residual tongue can be expected to 
have sufficient motility such as in patients with hemiglossectomy the oral 
floor is reconstructed by use of deltopectoral flap, forehead flap, pectoralis 
major myocutaneous flap or latissmus dorsi myocutaneous flap.  The post 
operative  oral  function  does  not  vary  much  with  the  method  of 
reconstruction.   The  myocutaneous  flap  has  a  great  advantage  in  that,  it 
makes single stage reconstruction possible.
Reconstruction  with  myocutaneous  flap  after  total  and  subtotal 
glossectomy.
It  is  easy  to  make  the  oral  floor  high  and  convex  by  the  use  of 
myocutaneous  flap.   But  it  is  likely  to  develop  secondary  atrophy 
particularly when the muscle is denervated.  To prevent secondary drooping 
of the oral floor.
1. An island flap must be designed about 1 to 1½ times as large as defect 
of the oral floor.  To prevent atrophy of the oral floor – innervation of the 
muscle must be preserved.  It is easier to use latissmus dorsi myocutaneous 
flap than a pectoralis major myocutaneous flap.
2. The posterior aspect of the oral defect should be  extended postero 
superiorly  until  it  comes  up  1/2   to  2/3  of  the  height  of  the  anterior 
glossopalatine  arch  an  island  flap  should  be  fixed  as  high  as  possible, 
posteriorly  by suturing at least unilaterally.
3. In  patients  who  underwent  total  glossectomy  the  transplanted 
myocutaneous  flap  can  be  suspended  superiorly  and  posteriorly    by 
medially transposed bilateral pterygoid muscles connected to each other by a 
fascia lata graft.
In some patients with T3 tongue cancer it is some times possible to 
resect the tongue and preserve a portion of its base, some of the muscles of 
the  oral  floor  and  hypoglossal  nerve  contralaterally.   In  all  these  cases 
secondary drooping of the reconstructed oral floor has been inconspicuous 
with excellent post operative  oral function for speech and deglutition.
Reconstruction  with  deltopectoral  flap  after  total  and  subtotal 
Glossectomy.
An  oral  floor  reconstructed  with  DP  flap  is  likely  to  develop 
secondary  atrophy  less  often  than  reconstructed  with  myocutaneous  flap. 
The DP flap must be long enough to reach the middle or posterior axillary 
line.  A simple covering of the oral defect is not sufficient to reconstruct the 
high oral floor.
To make the reconstructed oral floor high and convex, the broad flap, 
which is rotated and folded in the oral cavity to allow as much of the flap as 
possible to be inserted into the oral floor is sutured along the marginal of the 
oral defects.
MANAGEMENT OF THE NECK NODES
Unilateral neck node under 3 cm (NI)
Surgery is required to control lymph node metastasis in the neck.  The 
standard surgery for  dealing with metastatic  nodes in the neck is that  of 
Radical neck dissection described by Crile in 1906.  Various modifications 
of neck dissections then came out.
Metastasis in multiple nodes (N2b) or nodes larger than 3cm:
If there is more than one node in a neck and if there  is extra capsular 
spread the prognosis  is  worsen  by 100%.  The treatment  is  radical  neck 
dissection followed by post operative radiotherapy.
Bilateral Neck Nodes: N2c
Staged or simultaneous bilateral neck dissection may be advocated.  It 
is possible to carry out a neck dissection on both sides at same sitting with 
reasonable safety, although complications are high.  One side radical neck 
dissection and on the other side functional neck dissection can also be done.
Nodes greater than 6cm in size:
If  a  node is  greater  than 6 cm it  will  almost  certainly be fixed to 
adjacent  structures  and  will  have  exited  from the  node  capsule.   If  the 
tumour fixed to jugular vein it is a contraindication for surgery.  Fixation to 
the  base  of  the  skull  and  brachial  plexus  is  almost  contraindication  for 
surgery.  If it is fixed to overlying skin it is possible to resect the tumour 
with overlapping skin and reconstruct with myocutaneous flap.  When it is 
fixed to arterial tree, resection of the arterial tree and replaced by venous 
graft with great operative mortality.  As with N2 nodes, since the tumour 
had  exited  from the  lymph  node  capsule,  it  is  mandatory  to  follow any 
excisional operation with post operative radiotherapy.
No palpable metastasis Node-No:
Pathological involvement of nodes which is clinically not palpable is 
around 20%  in Carcinoma tongue especially in base of tongue tumours. 
Elective  neck dissection  has  some  place  in  whom unlikely  to  return  for 
follow  up.   Elective  Radical  neck  dissection  drastically  reduces  the 
recurrence rate in the same side of the neck.
TYPES OF NECK DISSECTIONS:
Radical Neck Dissection:
Removal of the entire cervical lymph node group extending from the 
inferior border of the mandible to clavicle and from the midline up to the 
anterior border of trapezius.  All level of nodes I to VI are included and 
spinal accessory nerve, internal jugular vein and sternomastoid muscle.
Modified Radical Neck Dissection (MRND)
Excision  of  all  lymph  node  groups  removed  by  the  radical  neck 
dissection with preservation of one or more of the below structures. Spinal 
accessory, Internal jugular vein, Sternomastoid muscle.
MRND Type I - Preserves spinal accessory nerve.
Type II - Preserves accessory nerve & sternocleidomastoid.
Type III - Preserves accessory nerve & sternocleidomastoid 
And Internal Jugular Vein.
Elective Neck Dissection:
Elective neck dissection will be carried in case of No neck nodes, that 
is  prophylactic neck dissection.   Surgery on No neck nodes has virtually 
been abandoned in favour of elective irradiation.
Selective Neck Dissection: This  refers  to  any  type  of  lymph  node 
removal  where  there  is  preservation  of  one  or  more  lymph node groups 
removed by the radical neck dissection.
1. Supra Omohyoid neck dissection:
Removal of level I, II, III nodes.  Posterior limits of dissections are 
cutaneous  branches  of  the  cervical  plexus  and  posterior  border  of  the 
sternomastoid  muscle.   Inferior  limit  is  the  superior  belly  of  omohyoid 
muscle where it crosses the internal jugular vein.
Postero lateral neck dissection:
Removal of lymph nodes in levels II, III, IV, V.
Antero lateral Neck dissection:
Removal of II, III, IV level nodes.
Central  Compartment neck dissection:
Removal of only level VI nodes.
Extended Radical Neck Dissection:
Removal of one or more additional lymph node groups and / or non 
lymphhatic structures that are not encompassed by radical neck dissection. 
This may include parapharyngeal, superior mediastinal, paratracheal lymph 
nodes.   Non-lymphatic  structures  might  include  the  cartoid  artery,  the 
hypoglossal nerve, the vagus nerve and paraspinal muscles.
MATERIALS AND METHODS
Totally 73 patients were chosen from the out patients departments of 
surgery, surgical oncology, ENT, Radiotherapy and medical oncology from 
the June 2006 to April  2008.   The patients were coming from the entire 
south  Tamil  Nadu because,  Govt.  Rajaji  Hospital,  Madurai  is  the highly 
equipped Teritary centre in South Tamil Nadu.  Some of the patients were 
treated locally at teaching institutions or Govt. hospitals and referred here 
for further management.
Majority of the patients attended our outpatient departments were in 
their late stage.  In our study roughly 73% of patients were belonging to the 
stage IV disease and only around 18% were stage I and Stage II.  Usually 
patients reported for ulcer over the tongue and pain over the ulcer.  Usually 
after the development of pain only, the patients visited the hospitals.
Invariably all the patients were having increased salivation.  Patients 
with Carcinoma of the posterior 1/3 of the tongue usually did not have any 
symptom at early stage.  In posterior 1/3 cancers, the patients visited for pain 
over the throat or swelling in the neck usually at the later stage and also have 
dysphagia.
We examined the patients  according to  the  proforma given below. 
Almost all the patients were with poor oral and dental hygiene.  Depending 
on the stage of the disease, patients were treated with surgery, radiotherapy 
and chemotherapy.
OBSERVATION AND RESULTS
Roughly 70% of the patients were more than 50 years and only 4.1% 
of patients were less than 30 years.
65.7%  of  the  patients  were  smoker.    Female  patients  were  not 
smokers.  Usually 10-15 beedies per day for more than 20-30 years.  All the 
patients  stopped  smoking  habits  once  the  symptom of  carcinoma  tongue 
developed usually the pain.
Roughly  35%  of  the  patients  were  tobacco  chewer  and  betal  nut 
chewer.  Majority of the patients keep them inside the oral cavity for long 
time even in the night. 
Caries teeth presented in 48% of the patients.  Premalignant lesions 
like leukoplakia were present in around 13% of the patients and submucous 
fibrosis presented in 3% of the patients.  Sharp teeth presented in about 49% 
of the patients, especially near the site of the ulcer or growth of the tongue. 
No sharp teeth presented in 51% of the patients.  This was due to loss of 
teeth for treatment purpose, caries teeth and poor dental hygiene.
Male  patients  especially  from  the  rural  area  invariably  were 
alcoholics.  Alcoholics constituted roughly about 54.7% of the patients.
When we examined the patients, right lateral border of the tongue was 
the usual  site  of  carcinoma of  the tongue.    Involvement  of  right  lateral 
border  was  45.2%.  Only  two patients  were  having lesions  at  tip  of  the 
tongue.   75% of  the  patients  presented  with  cervical  nodal  secondaries. 
Unilateral  involvement  of  nodes  was  around  54.5%  and  bilateral 
involvement was 41.2% of the patients.  Contra lateral nodes were involved 
in 4.3% of the patients.
FNAC was done in 92% of the nodal  positive cases.   We did not 
attempt in very small nodes.  The FNAC gave 72.7%  positive results for 
nodal metastasis.  Negative in 27.3% of patients.  It might be due to nodes 
per  se non metastatic  or  technically not  reached the metastatic  sites.   So 
FNAC is the ideal method to find out nodal metastasis.
More  than  50%  of  the  patients  were  subjected  to  surgical 
management.  2 patients were having small ulcer cover the tip of the tongue 
and were treated with excision of the ulcer and primary closure of the defect. 
Hemiglossectomy done is about 42.6% of the patients.  Surgery was done 
after primary radiotherapy in about 16.7% of the patients.
In the surgical patients block dissection done in 73.4% of the patients. 
68.4% of the block dissection were unilateral.  Nodes in the block dissection 
specimen were positive for metastasis in 74.6%.
Radiotherapy given to 68.4% of the patients under study  in which 
70% of the patients were treated primarily with radiotherapy.   Only 30% of 
the patients received post operative radiotherapy.
Neadjuvant  chemotherapy was not  given to  any patient.   Adjuvant 
chemotherapy along with radiotherapy was given to 16.4% and palliative 
chemotherapy given to the massive diseases was 12.3% of the patients.  The 
drugs we used were cisplatin, 5 FU, and Methotrexate.
Recurrence  rate  in  our  study was  28.7%.  After  surgery  alone  the 
recurrence was 23.8% and after radiotherapy alone 4.8%.  Recurrence was 
very much minimal with surgery followed by post operative radiotherapy 
which was 9.5%.
The  biopsy  report  for  all  the  patients  came  as  squamous  cell 
carcinoma. No  patient  had  reconstructive  procedure  after  surgical 
management of carcinoma of the tongue.
CONCLUSIONS FROM OUR STUDY
In our study the following conclusions were made.
1. It  is a male dominated disease.
2. Peak incidence is in the 5th and  6th decades of life.
3. Bad oral hygiene in the form of caries tooth is the commonest 
etiological factor in non smokers and smoking is the common 
etiological factors in smokers.
4. Summation effect is noted in carcinogenesis with bad oral hygiene 
(sharp and caries tooth) and alcoholism.
5. Lateral borders are the commonest area for tongue cancers indicating 
the dental role in carcinogenesis. In our study right  lateral border 
involvement is more common than left lateral border.
6. Nodal metastasis are quite high in our series indicating the late 
presentation of the patients and high metastatic capacity of the tongue 
cancers.
7. FNAC is the most easy, effective and accurate tool to establish the 
diagnosis of secondary carcinomatous lymphadenopathy (accuracy 
rate is >90%) with least complications.
8. Surgery for the primary tumour along with operative radiotherapy and 
block dissection for the secondary node, increases both disease free 
and overall survival.
9. Surgery is the main modality of treatment of carcinoma of the tongue 
due to the site involvement of as well as the high incidence of nodal 
metastasis.
10. Chemotherapy as palliation or adjuvant gives symptomatic relief but 
does not improve the overall survival.
11. Prognosis of the carcinoma of the tongue directly correlates with 
AJCC staging at the time of presentation.
12. Recurrence after a single modality of treatment (Radiotherapy) is 
higher than multimodality of treatment.
13. Though  various  methods  of  reconstructions  are  suggested  after 
surgical  resection  of   tongue,  our  patients  do  well  in  eating  and 
speaking  after  surgical  treatment  of  tongue  cancers  without  any 
reconstructive procedures.  This indicates the extensive capacity of the 
tongue for compensatory hyperplasia.
14. Radical glossectomy like subtotal glossectomy achieves better cancer 
clearance than wedge or partial glossectomy as indicated by increased 
recurrence rate in conservative surgery.
15. Carcinoma of the tongue is not an uncommon cancer in our area  and 
caries   bad  prognosis  among  the  oral  cancers  due  to  its  extensive 
lymph nodal metastasis.  It is also an agonising cancer in our study 
because of radiating ear pain, increased salivation, dysphagia etc.
16. Once intrinsic muscle of tongue is involved, the prognosis is bad.
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PROFORMA 
A STUDY ON CARCINOMA TONGUE 
Name : Address: D.O.A:
Age : D.O.S:
Sex : D.O.D:
H/O PRESENT ILLNESS
1. Ulcer / Swelling - Site
Duration
Onset
Progress
2. Pain - Onset
Nature
Site
Radiation
Referred pain over the ear
Pain during movement - On Swallowing - / On protrusion
3. Salivation - Increased / Normal
4. Movements of tongue - Normal / Pain during movements
- Deviation on protrusion Right / Left
- Inability to move
5. Voice - Normal / Dysarthria / Change in voice
6. Dysphagia - No dysphagia / Pain on swallowing / 
Inability to swallow
7. Smell - No bad smell / Bad smell / Bad smell to others
8. Bleeding from the lesion - Present / absent
9. Cough - Present / absent
10. Weight loss - Present / absent
11. Appetite - Normal / Loss of appelite
12. Taste - Normal / Altered taste / Loss of taste
H/O PAST ILLNESS
- Hypertensive / Normotensive
- Diabetes / Non diabetes
- Tuberculosis patient/ Non tuberculosis
- Multiple Exposure – present / absent
- Recurrent ulcer in the oral cavity – present /
Absent
- Previous swelling in the tongue – Present /
Absent
- Oral candidiasis
PERSONAL HISTORY
- Smoker / not a smoker
- Beedi / Cigarette / Cigar / Pipe
- Duration
- Alcoholic / not an alcoholic / duration / 
amount
- Betel nut chewer
- Tobacco chewer
- Snuff user
- Caries tooth – present / absent
- Syphilis – present / absent
- Dentures
EXAMINATION OF ORAL CAVITY
- Oral hygiene good / poor
- Dental hygiene good / poor
- Dental formula
- Caries tooth present / absent
- Leucoplakia present / absent
- Submucous Fibrosis present / absent
- Candidiasis present / absent
INSPECTION
1. Ulcer / growth - Site – Rt lateral / left / tip / dorsum / 
ventral surface / post 1/3
- Size
- Type / Fungating / ulcerating / 
Fissure/ Nodular / Frozen
- Color
- Surface
- Extension – floor of the mouth /
epiglottis / larynx  /  tonsil  /  Soft 
palate / side wall of pharynx
- Cross the midline – present / absent
2. Tongue :  Volume - Normal / Macroglossia
Color - White / red / blue / black hairy tongue
Crack / fissure - Transverse / Longitudinal
PALPATION
- Induration – Present / absent
- Bleeding – Present / absent
- Sharp tooth – present / absent
NODES : Sub mandibular – size / number /
 mobile /
immobile / consistency
Jugulo Diagastric Nodes : Size / Number / mobile / immobile /
Consistency
Jugulo Omohyoid Nodes : Size / Number / mobile / immobile /
Consistency
Submental Nodes : Present / absent
AUSCULATION : Creps in lungs – Present / absent
Biopsy : Type – wedge / punch / excision 
: Report – Lab  Yes /  No  
: Sq.cell ca / sarcoma / melanoma
FNAC from the nodes : Positive / Negative
STAGING: (TNM)
Treatment : Surgery
Block Dissection : Done / not done
: Unilateral / bilateral
: nodes – positive / negative
Reconstruction : Done /  not done
Radiotherapy : given / not given
: Brachytherapy / external beam
: Preoperative / Post operative
Chemotherapy : Given / not given
: Regimen
: Neo Adjuvant / adjuvant / palliative 
FOLLOW UP



